Stelios Pavlidis

3.4k total citations
29 papers, 673 citations indexed

About

Stelios Pavlidis is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Stelios Pavlidis has authored 29 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Physiology and 13 papers in Immunology. Recurrent topics in Stelios Pavlidis's work include Asthma and respiratory diseases (13 papers), IL-33, ST2, and ILC Pathways (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Stelios Pavlidis is often cited by papers focused on Asthma and respiratory diseases (13 papers), IL-33, ST2, and ILC Pathways (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Stelios Pavlidis collaborates with scholars based in United Kingdom, Netherlands and United States. Stelios Pavlidis's co-authors include Ian M. Adcock, Kian Fan Chung, Yike Guo, Chih‐Hsi S. Kuo, Anthony Rowe, Peter J. Sterk, Matthew J. Loza, Ratko Djukanović, René Lutter and Charles Auffray and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, The FASEB Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Stelios Pavlidis

27 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stelios Pavlidis United Kingdom 12 373 299 256 137 88 29 673
Hitasha Rupani United Kingdom 14 340 0.9× 256 0.9× 195 0.8× 167 1.2× 62 0.7× 53 665
Paul Rugman United Kingdom 10 470 1.3× 407 1.4× 271 1.1× 131 1.0× 54 0.6× 21 776
Emma Doran United Kingdom 9 352 0.9× 129 0.4× 333 1.3× 76 0.6× 92 1.0× 14 643
Nobutaka Edakuni Japan 14 286 0.8× 336 1.1× 95 0.4× 115 0.8× 46 0.5× 46 573
Madison G. Boswell United States 9 203 0.5× 70 0.2× 238 0.9× 38 0.3× 56 0.6× 12 432
William A. Fahy United Kingdom 16 319 0.9× 514 1.7× 54 0.2× 62 0.5× 22 0.3× 29 652
Akira Hoshioka Japan 13 184 0.5× 96 0.3× 164 0.6× 68 0.5× 30 0.3× 28 573
Nathalie Rouxel France 8 82 0.2× 70 0.2× 269 1.1× 201 1.5× 51 0.6× 9 431
Robert Virtala Sweden 8 103 0.3× 174 0.6× 98 0.4× 151 1.1× 23 0.3× 8 459
Chun‐Liang Chou Taiwan 12 76 0.2× 120 0.4× 262 1.0× 175 1.3× 35 0.4× 26 607

Countries citing papers authored by Stelios Pavlidis

Since Specialization
Citations

This map shows the geographic impact of Stelios Pavlidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stelios Pavlidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stelios Pavlidis more than expected).

Fields of papers citing papers by Stelios Pavlidis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stelios Pavlidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stelios Pavlidis. The network helps show where Stelios Pavlidis may publish in the future.

Co-authorship network of co-authors of Stelios Pavlidis

This figure shows the co-authorship network connecting the top 25 collaborators of Stelios Pavlidis. A scholar is included among the top collaborators of Stelios Pavlidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stelios Pavlidis. Stelios Pavlidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pavlidis, Stelios, Nazanin Zounemat Kermani, Katherine J. Baines, et al.. (2022). Pathways linked to unresolved inflammation and airway remodelling characterize the transcriptome in two independent severe asthma cohorts. Respirology. 27(9). 730–738. 7 indexed citations
2.
Allam, Venkata Sita Rama Raju, Stelios Pavlidis, Gang Liu, et al.. (2022). Macrophage migration inhibitory factor promotes glucocorticoid resistance of neutrophilic inflammation in a murine model of severe asthma. Thorax. 78(7). 661–673. 18 indexed citations
3.
Faiz, Alen, Stelios Pavlidis, Chih‐Hsi S. Kuo, et al.. (2022). Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD. Thorax. 78(4). 335–343. 16 indexed citations
4.
Tiotiu, Angélica, Nazanin Zounemat Kermani, Stelios Pavlidis, et al.. (2020). Sputum macrophage diversity and activation in asthma: Role of severity and inflammatory phenotype. Allergy. 76(3). 775–788. 28 indexed citations
5.
Kuo, Chih‐Hsi S., Chi‐Hsien Huang, Chien‐Ying Liu, et al.. (2019). Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib. Targeted Oncology. 14(4). 433–440. 10 indexed citations
6.
Huang, Shih‐Hao, Chin‐Chou Wang, Chien‐Ying Liu, et al.. (2019). Front‐line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control. Thoracic Cancer. 10(12). 2274–2281. 3 indexed citations
7.
Pavlidis, Stelios, Calixte S. Monast, Matthew J. Loza, et al.. (2019). I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatment. PLoS Computational Biology. 15(4). e1006951–e1006951. 16 indexed citations
8.
Kuo, Chih‐Hsi S., Chin‐Chou Wang, Yu‐Chen Huang, et al.. (2019). Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer. Thoracic Cancer. 10(5). 1158–1166. 19 indexed citations
9.
Pavlidis, Stelios, Peter Wark, Daniel Barker, et al.. (2019). Sputum gene signature comparison study between U-BIOPRED and Australia asthma cohorts. Spiral (Imperial College London). PA5405–PA5405. 1 indexed citations
10.
Emam, Ibrahim, Stelios Pavlidis, Philippe Rocca‐Serra, et al.. (2019). PlatformTM, a standards-based data custodianship platform for translational medicine research. Scientific Data. 6(1). 149–149. 3 indexed citations
11.
Yan, Xiaoyi, Jiayan Xu, Yaqi Meng, et al.. (2018). Ezrin, a Membrane Cytoskeleton Cross-Linker Protein, as a Marker of Epithelial Damage in Asthma. American Journal of Respiratory and Critical Care Medicine. 199(4). 496–507. 39 indexed citations
12.
Huang, Yu‐Chen, Chien‐Ying Liu, Stelios Pavlidis, et al.. (2018). Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR‐mutant and EGFR‐wild type nonsquamous non‐small cell lung cancer. Thoracic Cancer. 9(12). 1648–1655. 3 indexed citations
13.
Kwong, Francois Ng Kee, Andrew G. Nicholson, Stelios Pavlidis, Ian M. Adcock, & Kian Fan Chung. (2018). PGAM5 expression and macrophage signatures in non-small cell lung cancer associated with chronic obstructive pulmonary disease (COPD). BMC Cancer. 18(1). 1238–1238. 16 indexed citations
14.
15.
Ravanetti, Lara, Annemiek Dijkhuis, Tamara Dekker, et al.. (2018). IL-33 drives influenza-induced asthma exacerbations by halting innate and adaptive antiviral immunity. Journal of Allergy and Clinical Immunology. 143(4). 1355–1370.e16. 83 indexed citations
16.
Pavlidis, Stelios, et al.. (2017). Mitochondrial-Related Gene Expression and Macrophage Signatures in Non-Small Cell Lung Cancer, Including Patients with Emphysema as Co-Morbidity. Journal of Clinical & Cellular Immunology. 8(3). 1 indexed citations
17.
Haw, Tatt Jhong, Malcolm R. Starkey, Stelios Pavlidis, et al.. (2017). Toll-like receptor 2 and 4 have Opposing Roles in the Pathogenesis of Cigarette Smoke-induced Chronic Obstructive Pulmonary Disease. American Journal of Physiology-Lung Cellular and Molecular Physiology. 314(2). ajplung.00154.2–ajplung.00154.2. 49 indexed citations
18.
Lee, Jin, Matthew Machin, Kirsty Russell, et al.. (2016). Corticosteroid modulation of immunoglobulin expression and B‐cell function in COPD. The FASEB Journal. 30(5). 2014–2026. 24 indexed citations
19.
Haw, Tatt Jhong, Malcolm R. Starkey, Prema M. Nair, et al.. (2015). A pathogenic role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive pulmonary disease. Mucosal Immunology. 9(4). 859–872. 52 indexed citations
20.
Loza, Matthew J., Stelios Pavlidis, Anthony Rowe, et al.. (2015). Systemic corticosteroid-associated serum analyte profiles in the U-BIOPRED severe asthma cohort. OA1774–OA1774. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hitasha Rupani Breakdown of academic impact, for papers by Paul Rugman Breakdown of academic impact, for papers by Emma Doran Breakdown of academic impact, for papers by Nobutaka Edakuni Breakdown of academic impact, for papers by Madison G. Boswell Breakdown of academic impact, for papers by William A. Fahy Breakdown of academic impact, for papers by Akira Hoshioka Breakdown of academic impact, for papers by Nathalie Rouxel Breakdown of academic impact, for papers by Robert Virtala Breakdown of academic impact, for papers by Chun‐Liang Chou
Rankless by CCL
2026